Correlation Between CRISPR Therapeutics and DocuSign
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and DocuSign at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and DocuSign into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and DocuSign, you can compare the effects of market volatilities on CRISPR Therapeutics and DocuSign and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of DocuSign. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and DocuSign.
Diversification Opportunities for CRISPR Therapeutics and DocuSign
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between CRISPR and DocuSign is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and DocuSign in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DocuSign and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with DocuSign. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DocuSign has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and DocuSign go up and down completely randomly.
Pair Corralation between CRISPR Therapeutics and DocuSign
Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to under-perform the DocuSign. But the stock apears to be less risky and, when comparing its historical volatility, CRISPR Therapeutics AG is 1.49 times less risky than DocuSign. The stock trades about -0.13 of its potential returns per unit of risk. The DocuSign is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 2,400 in DocuSign on November 3, 2024 and sell it today you would earn a total of 456.00 from holding DocuSign or generate 19.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.56% |
| Values | Daily Returns |
CRISPR Therapeutics AG vs. DocuSign
Performance |
| Timeline |
| CRISPR Therapeutics |
| DocuSign |
CRISPR Therapeutics and DocuSign Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CRISPR Therapeutics and DocuSign
The main advantage of trading using opposite CRISPR Therapeutics and DocuSign positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, DocuSign can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocuSign will offset losses from the drop in DocuSign's long position.The idea behind CRISPR Therapeutics AG and DocuSign pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| DocuSign vs. United Rentals | DocuSign vs. Broadridge Financial Solutions, | DocuSign vs. MAHLE Metal Leve | DocuSign vs. Metalrgica Riosulense SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |